Skip to main content

Advertisement

Log in

Severe sustained hypoplastic bone marrow after immunosuppressive therapy in malignant lymphoma cases with anti-centromere protein-B antibody

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Dufresne SD, Felgar RE, Sargent RL, Surti U, Gollin SM, McPhail ED, Cook JR, Swerdlow SH (2010) Defining the borders of splenic marginal zone lymphoma: a multiparameter study. Hum Pathol 41:540–551

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. Boveri E, Arcaini L, Merli M, Passamonti F, Rizzi S, Vanelli L, Rumi E, Rattotti S, Lucioni M, Picone C, Castello A, Pascutto C, Magrini U, Lazzarino M, Paulli M (2009) Bone marrow histology in marginal zone B-cell lymphomas: correlation with clinical parameters and flow cytometry in 120 patients. Ann Oncol 20:129–136

    Article  CAS  PubMed  Google Scholar 

  3. Audouin J, Le Tourneau A, Molina T, Camilleri-Broët S, Adida C, Comperat E, Benattar L, Delmer A, Devidas A, Rio B, Diebold J (2003) Patterns of bone marrow involvement in 58 patients presenting primary splenic marginal zone lymphoma with or without circulating villous lymphocytes. Br J Haematol 122:404–412

    Article  PubMed  Google Scholar 

  4. Franco V, Florena AM, Iannitto E (2003) Splenic marginal zone lymphoma. Blood 101:2464–2472

    Article  CAS  PubMed  Google Scholar 

  5. Earnshaw W, Bordwell B, Marino C, Rothfield N (1986) Three human chromosomal autoantigens are recognized by sera from patients with anti-centromere antibodies. J Clin Invest 77:426–430

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Gelber AC, Pillemer SR, Baum BJ, Wigley FM, Hummers LK, Morris S, Rosen A, Casciola-Rosen L (2006) Distinct recognition of antibodies to centromere proteins in primary Sjogren’s syndrome compared with limited scleroderma. Ann Rheum Dis 65:1028–1032

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Miyawaki S, Asanuma H, Nishiyama S, Yoshinaga Y (2005) Clinical and serological heterogeneity in patients with anticentromere antibodies. J Rheumatol 32:1488–1494

    PubMed  Google Scholar 

Download references

Funding

We have no funding support.

Conflict of interest

The authors declare that they have no competing interests.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rie Tabata.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tabata, R., Tabata, C., Yasumizu, R. et al. Severe sustained hypoplastic bone marrow after immunosuppressive therapy in malignant lymphoma cases with anti-centromere protein-B antibody. Ann Hematol 94, 1589–1591 (2015). https://doi.org/10.1007/s00277-015-2398-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-015-2398-8

Keywords

Navigation